Mark H. Eckman

9.1k total citations · 2 hit papers
145 papers, 6.4k citations indexed

About

Mark H. Eckman is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Economics and Econometrics. According to data from OpenAlex, Mark H. Eckman has authored 145 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Cardiology and Cardiovascular Medicine, 35 papers in Internal Medicine and 30 papers in Economics and Econometrics. Recurrent topics in Mark H. Eckman's work include Atrial Fibrillation Management and Outcomes (44 papers), Venous Thromboembolism Diagnosis and Management (35 papers) and Health Systems, Economic Evaluations, Quality of Life (28 papers). Mark H. Eckman is often cited by papers focused on Atrial Fibrillation Management and Outcomes (44 papers), Venous Thromboembolism Diagnosis and Management (35 papers) and Health Systems, Economic Evaluations, Quality of Life (28 papers). Mark H. Eckman collaborates with scholars based in United States, Canada and Spain. Mark H. Eckman's co-authors include Daniel E. Singer, Steven M. Greenberg, Stephen G. Pauker, Frederick A. Spencer, Jonathan Rosand, Andrew Dunn, Amir K. Jaffer, Alex C. Spyropoulos, Katherine Knudsen and James D. Douketis and has published in prestigious journals such as New England Journal of Medicine, JAMA and Nature Medicine.

In The Last Decade

Mark H. Eckman

141 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Perioperative Management of Antithrombotic Therapy

2012 1.1k citations Mark H. Eckman et al. profile →
Antithrombotic Therapy for Atrial Fibrillation

2012 697 citations Mark H. Eckman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark H. Eckman United States	37	3.2k	1.7k	1.5k	1.1k	814	145	6.4k
Scott Kaatz United States	38	4.5k 1.4×	3.2k 1.8×	770 0.5×	907 0.8×	396 0.5×	167	7.1k
Laine Thomas United States	58	8.9k 2.8×	2.3k 1.3×	1.3k 0.8×	1.2k 1.1×	275 0.3×	257	11.4k
Rebecca J. Beyth United States	29	3.0k 0.9×	2.5k 1.4×	567 0.4×	1.1k 1.0×	181 0.2×	84	5.9k
Uwe Janssens Germany	36	2.1k 0.6×	848 0.5×	918 0.6×	1.5k 1.4×	380 0.5×	228	5.7k
Andreas Laupacis Canada	48	3.2k 1.0×	1.1k 0.6×	1.5k 1.0×	2.1k 1.9×	255 0.3×	98	9.7k
Jeffrey A. Kline United States	46	3.3k 1.0×	4.5k 2.6×	2.2k 1.4×	1.6k 1.5×	291 0.4×	239	9.1k
LG Mantovani Italy	44	2.8k 0.9×	1.2k 0.7×	911 0.6×	677 0.6×	193 0.2×	366	7.8k
Alpesh Amin United States	36	2.0k 0.6×	1.1k 0.6×	523 0.3×	758 0.7×	186 0.2×	257	5.3k
Robby Nieuwlaat Canada	39	12.3k 3.8×	4.0k 2.3×	2.3k 1.5×	1.0k 0.9×	501 0.6×	110	16.4k
Daniel M. Witt United States	31	3.1k 1.0×	2.2k 1.3×	472 0.3×	610 0.6×	252 0.3×	153	4.5k

Countries citing papers authored by Mark H. Eckman

Since Specialization

Citations

This map shows the geographic impact of Mark H. Eckman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Eckman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Eckman more than expected).

Fields of papers citing papers by Mark H. Eckman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark H. Eckman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Eckman. The network helps show where Mark H. Eckman may publish in the future.

Co-authorship network of co-authors of Mark H. Eckman

This figure shows the co-authorship network connecting the top 25 collaborators of Mark H. Eckman. A scholar is included among the top collaborators of Mark H. Eckman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark H. Eckman. Mark H. Eckman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xie, Feng, Elizabeth H. Golembiewski, Mark H. Eckman, et al.. (2024). Values and preferences towards the use of prophylactic low-molecular-weight heparin during pregnancy: a convergent mixed-methods secondary analysis of data from the decision analysis in shared decision making for thromboprophylaxis during pregnancy (DASH-TOP) study. Thrombosis Journal. 22(1). 81–81. 2 indexed citations

Wima, Koffi, Brett Harnett, John R. Kues, et al.. (2023). Lung cancer screening utilization rate varies based on patient, provider, and hospital factors. Journal of Thoracic and Cardiovascular Surgery. 166(5). 1331–1339. 4 indexed citations

Martinez, Kathryn A., et al.. (2022). Prescribing of anticoagulation for atrial fibrillation in primary care. Journal of Thrombosis and Thrombolysis. 54(4). 616–624. 3 indexed citations

Gulati, Shuchi & Mark H. Eckman. (2022). Anticoagulant Therapy for Cancer-Associated Thrombosis. Annals of Internal Medicine. 176(1). 1–9. 14 indexed citations

Canelo‐Aybar, Carlos, Claudia Valli, Kevin Pacheco‐Barrios, et al.. (2021). More work needed on decision analysis for shared decision-making: A scoping review. Journal of Clinical Epidemiology. 141. 106–120. 4 indexed citations

Eckman, Mark H., Heather J. Duncan, E. Steve Woodle, et al.. (2021). Incorporating Patients’ Values and Preferences Into Decision Making About Transplantation of HCV-Naïve Recipients With Kidneys From HCV-Viremic Donors: A Feasibility Study. MDM Policy & Practice. 6(2). 87803289–87803289. 1 indexed citations

Bates, Shannon M., Gordon Guyatt, Mark H. Eckman, et al.. (2021). Decision Analysis in SHared decision making for Thromboprophylaxis during Pregnancy (DASH-TOP): a sequential explanatory mixed methods pilot study protocol. BMJ Open. 11(3). e046021–e046021. 5 indexed citations

Doers, Matthew E., Muhammad Ahsan Zafar, Uwe Stolz, et al.. (2021). Predicting Adverse Events Among Patients With COPD Exacerbations in the Emergency Department. Respiratory Care. 67(1). 56–65. 3 indexed citations

Eckman, Mark H., et al.. (2020). Automated Tool for Health Utility Assessments: The Gambler II. MDM Policy & Practice. 5(1). 3444562819–3444562819. 5 indexed citations

10.

Robinson, Bryce R. H., et al.. (2019). Cervical spine evaluation in pediatric trauma: A cost-effectiveness analysis. The American Journal of Emergency Medicine. 38(11). 2347–2355. 6 indexed citations

11.

Gupta, Nishant, et al.. (2016). Chest Computed Tomographic Image Screening for Cystic Lung Diseases in Patients with Spontaneous Pneumothorax Is Cost Effective. Annals of the American Thoracic Society. 14(1). 17–25. 35 indexed citations

12.

Abbott, Daniel E., Matthew T. McMillan, Mark P. Callery, et al.. (2016). Pancreas fistula risk prediction: implications for hospital costs and payments. HPB. 19(2). 140–146. 14 indexed citations

13.

Abbott, Daniel E., Jeffrey M. Sutton, Peter L. Jernigan, et al.. (2015). How Much Should We Pay to Minimize Pancreatic Leak? The Cost-effectiveness of Pasireotide in Pancreatic Resection. Annals of Surgery. Publish Ahead of Print. 1 indexed citations

14.

Eckman, Mark H., Andrew H. Talal, Stuart C. Gordon, Eugene R. Schiff, & Kenneth E. Sherman. (2013). Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States. Clinical Infectious Diseases. 56(10). 1382–1393. 100 indexed citations

15.

Ward, Michael J., Mark H. Eckman, Daniel P. Schauer, Ali S. Raja, & Sean P. Collins. (2011). Cost‐effectiveness of Telemetry for Hospitalized Patients With Low‐risk Chest Pain. Academic Emergency Medicine. 18(3). 279–286. 17 indexed citations

16.

Wilson, Stephen E., et al.. (2010). Understanding preferences for disclosure of individual biomarker results among participants in a longitudinal birth cohort. Journal of Medical Ethics. 36(12). 736–740. 7 indexed citations

17.

Thakar, Charuhas V., et al.. (2009). Outcomes of Hemodialysis Patients in a Long-term Care Hospital Setting: A Single-Center Study. American Journal of Kidney Diseases. 55(2). 300–306. 22 indexed citations

18.

Johnston, Joseph A., Patrick Brill-Edwards, Jeffrey S. Ginsberg, Stephen G. Pauker, & Mark H. Eckman. (2005). Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism. The American Journal of Medicine. 118(5). 503–514. 18 indexed citations

19.

Schauer, Daniel P., et al.. (2005). Psychosocial risk factors for adverse outcomes in patients with nonvalvular atrial fibrillation receiving warfarin. Journal of General Internal Medicine. 20(12). 1114–1119. 42 indexed citations

20.

Yi, Michael, Maria T. Britto, Robert W. Wilmott, et al.. (2003). Health values of adolescents with cystic fibrosis. The Journal of Pediatrics. 142(2). 133–140. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact